参考文献/References:
[1] Pedersen BK,Febbraio MA. Muscles, exercise and obesity： skeletal muscle as a secretory organ[J]. Nat Rev Endocrinol,2012,8（8）： 457-465.
[2] Teufel A,Malik N,Mukhopadhyay M,et a1. Frcpl and Frop2,two novel fibronectin type Ⅲ repeat containing genes[J]. Gene,2002,
297（1-2）：79-83.
[3] Ferrer-Martínez A,Ruiz-Lozano P,Chien KR. Mouse PeP：a novel peroxisomal protein linked to myoblast differentiation and development[J]. Dev Dyn,2002,224（2）：154-167.
[4] Bostr?觟m P,Wu J,Jedrychowski MP,et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis[J]. Nature,2012,481（7382）：463-468.
[5] Dun SL,Lyu RM,Chen YH,et al. Irisin-immunoreactivity in neural and non-neural cells of the rodent[J].Neuroscience,2013,
240：155-162.
[6] Huh JY,Panagiotou G,Mougios V,et al. FNDC5 and irisin in humans：I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentra-tions in response to weight loss and exercise[J]. Metabolism,2012,61（12）：1725-1738.
[7] Castillo-Quan JI. From white to brown fat through the PGC-1 alpha-dependent myokine irisin：implications for diabetes and obesity[J]. Dis Model Mech,2012,5（3）：293-295.
[8] Villarroya F. Irisin,turning up the heat[J]. Cell Metab,2012,15（3）：277-278.
[9] Shan T,Liang X,Bi P,et al. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1alpha-Fndc5 pathway in muscle[J]. FASEB J,2013,27（5）：1981-1989.
[10] Hashemi MS,Ghaedi K,Salamian A,et al. Fndc5 knockdown significantly decreased neural differentiation rate of mouse embryonic stem cells[J]. Neuroscience,2013,231：296-304.
[11] Moon HS,Dincer F,Mantzoros CS. Pharmacological concentra-tions of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines[J]. Metabolism,2013,62（8）：1131-1136.
[12] Timmons JA,Baar K,Davidsen PK,et al. Is irisin a human exercise gene?[J].Nature,2012,488（7413）：E9-10；discussion E10-11.
[13] Liu JJ,Wong MD,Toy WC,et al. Lower circulating irisin is associated with type 2 diabetes mellitus[J].J Diabetes Com-plications, 2013,27（4）：365-369.
[14] Stengel A,Hofmann T,Goebel-Stengel M,et al. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index[J].Peptides,2013,39：125-130.
[15] Moreno-Navarrete JM,Ortega F,Serrano M,et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance[J].J Clin Endocrinol Metab, 2013,98（4）：E769-E778.
[16] Choi YK,Kim MK,Bae KH,et al. Serum irisin levels in new-onset type 2 diabetes[J]. Diabetes Res Clin Pract,2013,100（1）：96-101.
[17] Roberts MD,Bayless DS,Company JM,et al. Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats[J].Metabolism,2013,62（8）：1052-1056.
[18] Swick AG,Orena S,O'Connor A. Irisin levels correlate with energy expenditure in a subgroup of humans with energy expen-diture greater than predicted by fat free mass[J]. Metabolism,2013,62（8）： 1070-1073.
[19] Sharma N,Castorena CM,Cartee GD. Greater insulin sensitivity in calorie restricted rats occurs with unaltered circulating levels of several important myokines and cytokines[J]. Nutr Metab（Lond）,2012,9（1）：90.
[20] Zhang HJ,Zhang XF,Ma ZM,et al. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults[J]. J Hepatol, 2013,59（3）：557-562.
[21] Wen MS,Wang CY,Lin SL,et al. Decrease in irisin in patients with chronic kidney disease[J]. PLoS One,2013,8（5）：e64025.
[22] Al-Daghri NM,Alkharfy KM,Rahman S,et al.Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects[J]. Eur J Clin Invest,2013,[Epub ahead of print].
相似文献/References:
[1]李爱玲,谢云,李瑾,等.体重指数和腰臀比预测非酒精性脂肪性肝病发病风险的比较[J].国际内分泌代谢杂志,2014,(02):135.[doi:10.3760/cma.j.issn.1673-4157.2014.02.018]
Li Ailing,Xie Yun,Li Jin,et al.Comparison of body mass index and waist-to-hip ratio for predicting of non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2014,(02):135.[doi:10.3760/cma.j.issn.1673-4157.2014.02.018]
[2]艾华,谢岚.Irisin与代谢性疾病的关系[J].国际内分泌代谢杂志,2014,(05):316.[doi:10.3760/cma.j.issn.1673-4157.2014.05.008]
Ai Hua,Xie Lan.Relationship between irisin and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(02):316.[doi:10.3760/cma.j.issn.1673-4157.2014.05.008]
[3]陈恺情,卜瑞芳.Irisin——可否让代谢性疾病治疗进入新时代[J].国际内分泌代谢杂志,2016,36(01):38.[doi:10.3760/cma.j.issn.1673-4157.2016.01.009]
Chen Kaiqing,Bu Ruifang..Could irisin lead the treatment of metabolic diseases into a new era?[J].International Journal of Endocrinology and Metabolism,2016,36(02):38.[doi:10.3760/cma.j.issn.1673-4157.2016.01.009]
[4]邹家琦,丁雪洁,孙鹏,等.体重指数对胰岛分离产量及胰岛功能的影响[J].国际内分泌代谢杂志,2021,41(05):445.[doi:10.3760/cma.j.cn121383-20201204-12015]
Zou Jiaqi,Ding Xuejie,Sun Peng,et al.The influence of body mass index on islet isolation outcome and function[J].International Journal of Endocrinology and Metabolism,2021,41(02):445.[doi:10.3760/cma.j.cn121383-20201204-12015]